Use of human papillomavirus vaccines among young adult women in the United States

An analysis of the 2008 National Health Interview Survey

Rebecca Anhang Price, Jasmin A. Tiro, Mona Saraiya, Helen Meissner, Nancy Breen

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

BACKGROUND: The Centers for Disease Control and Prevention recommends catch-up administration of human papillomavirus (HPV) vaccines to girls and women ages 13 to 26 who have not been vaccinated previously. In response to debate regarding catch-up vaccination of young adult women, this study examined whether 18- to 26-year-old women most likely to benefit from catch-up vaccination were aware of the HPV vaccine, and initiated the vaccine series by the end of 2008. METHODS: We used data from the 2008 National Health Interview Survey to assess HPV vaccine awareness and use, and reasons for not vaccinating, among women aged 18-26 years (n = 1583). Sociodemographic, health care access, and health history factors associated with vaccine initiation were assessed using multivariate logistic regression. RESULTS: Overall, 11.7% of women aged 18-26 years reported receiving at least 1 dose of the HPV vaccine by the end of 2008. In multivariate analyses, younger age, history of previous HPV infection, unmarried status, health insurance, flu shot in the past year, and receipt of 1 or more recommended lifetime vaccines were significantly associated with HPV vaccine initiation. Two-fifths (39.6%) of unvaccinated women were interested in receiving the HPV vaccine (n = 1327). Primary reasons for lack of interest in the vaccine were belief that it was not needed, not knowing enough about it, concerns about safety, and not being sexually active. CONCLUSION: HPV vaccine coverage among young adult women was low, and lower among the uninsured than the insured. Public financing and care provision programs have the potential to expand vaccine coverage among uninsured women, who are at increased risk of cervical cancer.

Original languageEnglish (US)
Pages (from-to)5560-5568
Number of pages9
JournalCancer
Volume117
Issue number24
DOIs
StatePublished - Dec 15 2011

Fingerprint

Papillomavirus Vaccines
Health Surveys
Young Adult
Interviews
Vaccines
Vaccination
Government Financing
Papillomavirus Infections
Health Insurance
Centers for Disease Control and Prevention (U.S.)
Uterine Cervical Neoplasms
Multivariate Analysis
Logistic Models
Delivery of Health Care
Safety

Keywords

  • cervical cancer
  • disparities
  • human papillomavirus
  • vaccines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Use of human papillomavirus vaccines among young adult women in the United States : An analysis of the 2008 National Health Interview Survey. / Anhang Price, Rebecca; Tiro, Jasmin A.; Saraiya, Mona; Meissner, Helen; Breen, Nancy.

In: Cancer, Vol. 117, No. 24, 15.12.2011, p. 5560-5568.

Research output: Contribution to journalArticle

Anhang Price, Rebecca ; Tiro, Jasmin A. ; Saraiya, Mona ; Meissner, Helen ; Breen, Nancy. / Use of human papillomavirus vaccines among young adult women in the United States : An analysis of the 2008 National Health Interview Survey. In: Cancer. 2011 ; Vol. 117, No. 24. pp. 5560-5568.
@article{3a9aa16c1918485c84d840df4d85614c,
title = "Use of human papillomavirus vaccines among young adult women in the United States: An analysis of the 2008 National Health Interview Survey",
abstract = "BACKGROUND: The Centers for Disease Control and Prevention recommends catch-up administration of human papillomavirus (HPV) vaccines to girls and women ages 13 to 26 who have not been vaccinated previously. In response to debate regarding catch-up vaccination of young adult women, this study examined whether 18- to 26-year-old women most likely to benefit from catch-up vaccination were aware of the HPV vaccine, and initiated the vaccine series by the end of 2008. METHODS: We used data from the 2008 National Health Interview Survey to assess HPV vaccine awareness and use, and reasons for not vaccinating, among women aged 18-26 years (n = 1583). Sociodemographic, health care access, and health history factors associated with vaccine initiation were assessed using multivariate logistic regression. RESULTS: Overall, 11.7{\%} of women aged 18-26 years reported receiving at least 1 dose of the HPV vaccine by the end of 2008. In multivariate analyses, younger age, history of previous HPV infection, unmarried status, health insurance, flu shot in the past year, and receipt of 1 or more recommended lifetime vaccines were significantly associated with HPV vaccine initiation. Two-fifths (39.6{\%}) of unvaccinated women were interested in receiving the HPV vaccine (n = 1327). Primary reasons for lack of interest in the vaccine were belief that it was not needed, not knowing enough about it, concerns about safety, and not being sexually active. CONCLUSION: HPV vaccine coverage among young adult women was low, and lower among the uninsured than the insured. Public financing and care provision programs have the potential to expand vaccine coverage among uninsured women, who are at increased risk of cervical cancer.",
keywords = "cervical cancer, disparities, human papillomavirus, vaccines",
author = "{Anhang Price}, Rebecca and Tiro, {Jasmin A.} and Mona Saraiya and Helen Meissner and Nancy Breen",
year = "2011",
month = "12",
day = "15",
doi = "10.1002/cncr.26244",
language = "English (US)",
volume = "117",
pages = "5560--5568",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "24",

}

TY - JOUR

T1 - Use of human papillomavirus vaccines among young adult women in the United States

T2 - An analysis of the 2008 National Health Interview Survey

AU - Anhang Price, Rebecca

AU - Tiro, Jasmin A.

AU - Saraiya, Mona

AU - Meissner, Helen

AU - Breen, Nancy

PY - 2011/12/15

Y1 - 2011/12/15

N2 - BACKGROUND: The Centers for Disease Control and Prevention recommends catch-up administration of human papillomavirus (HPV) vaccines to girls and women ages 13 to 26 who have not been vaccinated previously. In response to debate regarding catch-up vaccination of young adult women, this study examined whether 18- to 26-year-old women most likely to benefit from catch-up vaccination were aware of the HPV vaccine, and initiated the vaccine series by the end of 2008. METHODS: We used data from the 2008 National Health Interview Survey to assess HPV vaccine awareness and use, and reasons for not vaccinating, among women aged 18-26 years (n = 1583). Sociodemographic, health care access, and health history factors associated with vaccine initiation were assessed using multivariate logistic regression. RESULTS: Overall, 11.7% of women aged 18-26 years reported receiving at least 1 dose of the HPV vaccine by the end of 2008. In multivariate analyses, younger age, history of previous HPV infection, unmarried status, health insurance, flu shot in the past year, and receipt of 1 or more recommended lifetime vaccines were significantly associated with HPV vaccine initiation. Two-fifths (39.6%) of unvaccinated women were interested in receiving the HPV vaccine (n = 1327). Primary reasons for lack of interest in the vaccine were belief that it was not needed, not knowing enough about it, concerns about safety, and not being sexually active. CONCLUSION: HPV vaccine coverage among young adult women was low, and lower among the uninsured than the insured. Public financing and care provision programs have the potential to expand vaccine coverage among uninsured women, who are at increased risk of cervical cancer.

AB - BACKGROUND: The Centers for Disease Control and Prevention recommends catch-up administration of human papillomavirus (HPV) vaccines to girls and women ages 13 to 26 who have not been vaccinated previously. In response to debate regarding catch-up vaccination of young adult women, this study examined whether 18- to 26-year-old women most likely to benefit from catch-up vaccination were aware of the HPV vaccine, and initiated the vaccine series by the end of 2008. METHODS: We used data from the 2008 National Health Interview Survey to assess HPV vaccine awareness and use, and reasons for not vaccinating, among women aged 18-26 years (n = 1583). Sociodemographic, health care access, and health history factors associated with vaccine initiation were assessed using multivariate logistic regression. RESULTS: Overall, 11.7% of women aged 18-26 years reported receiving at least 1 dose of the HPV vaccine by the end of 2008. In multivariate analyses, younger age, history of previous HPV infection, unmarried status, health insurance, flu shot in the past year, and receipt of 1 or more recommended lifetime vaccines were significantly associated with HPV vaccine initiation. Two-fifths (39.6%) of unvaccinated women were interested in receiving the HPV vaccine (n = 1327). Primary reasons for lack of interest in the vaccine were belief that it was not needed, not knowing enough about it, concerns about safety, and not being sexually active. CONCLUSION: HPV vaccine coverage among young adult women was low, and lower among the uninsured than the insured. Public financing and care provision programs have the potential to expand vaccine coverage among uninsured women, who are at increased risk of cervical cancer.

KW - cervical cancer

KW - disparities

KW - human papillomavirus

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=82955212820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955212820&partnerID=8YFLogxK

U2 - 10.1002/cncr.26244

DO - 10.1002/cncr.26244

M3 - Article

VL - 117

SP - 5560

EP - 5568

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 24

ER -